Global Biologics Market Insights and Forecast to 2026

Global Biologics Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Biologics Product Introduction
1.2 Market Segments
1.3 Key Biologics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biologics Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies
1.4.3 Vaccines
1.4.4 Recombinant Proteins
1.4.5 Antisense
1.4.6 RNAi
1.5 Market by Application
1.5.1 Global Biologics Market Size Growth Rate by Application
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Immunology
1.5.5 Autoimmune Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Biologics Market Size, Estimates and Forecasts
2.1.1 Global Biologics Revenue 2015-2026
2.1.2 Global Biologics Sales 2015-2026
2.2 Global Biologics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biologics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biologics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biologics Competitor Landscape by Players
3.1 Biologics Sales by Manufacturers
3.1.1 Biologics Sales by Manufacturers (2015-2020)
3.1.2 Biologics Sales Market Share by Manufacturers (2015-2020)
3.2 Biologics Revenue by Manufacturers
3.2.1 Biologics Revenue by Manufacturers (2015-2020)
3.2.2 Biologics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biologics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biologics Revenue in 2019
3.2.5 Global Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biologics Price by Manufacturers
3.4 Biologics Manufacturing Base Distribution, Product Types
3.4.1 Biologics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biologics Product Type
3.4.3 Date of International Manufacturers Enter into Biologics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Biologics Market Size by Type (2015-2020)
4.1.1 Global Biologics Sales by Type (2015-2020)
4.1.2 Global Biologics Revenue by Type (2015-2020)
4.1.3 Biologics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biologics Market Size Forecast by Type (2021-2026)
4.2.1 Global Biologics Sales Forecast by Type (2021-2026)
4.2.2 Global Biologics Revenue Forecast by Type (2021-2026)
4.2.3 Biologics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biologics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Biologics Market Size by Application (2015-2020)
5.1.1 Global Biologics Sales by Application (2015-2020)
5.1.2 Global Biologics Revenue by Application (2015-2020)
5.1.3 Biologics Price by Application (2015-2020)
5.2 Biologics Market Size Forecast by Application (2021-2026)
5.2.1 Global Biologics Sales Forecast by Application (2021-2026)
5.2.2 Global Biologics Revenue Forecast by Application (2021-2026)
5.2.3 Global Biologics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biologics by Country
6.1.1 North America Biologics Sales by Country
6.1.2 North America Biologics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biologics Market Facts & Figures by Type
6.3 North America Biologics Market Facts & Figures by Application
7 Europe
7.1 Europe Biologics by Country
7.1.1 Europe Biologics Sales by Country
7.1.2 Europe Biologics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biologics Market Facts & Figures by Type
7.3 Europe Biologics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biologics by Region
8.1.1 Asia Pacific Biologics Sales by Region
8.1.2 Asia Pacific Biologics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biologics Market Facts & Figures by Type
8.3 Asia Pacific Biologics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biologics by Country
9.1.1 Latin America Biologics Sales by Country
9.1.2 Latin America Biologics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biologics Market Facts & Figures by Type
9.3 Central & South America Biologics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biologics by Country
10.1.1 Middle East and Africa Biologics Sales by Country
10.1.2 Middle East and Africa Biologics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biologics Market Facts & Figures by Type
10.3 Middle East and Africa Biologics Market Facts & Figures by Application
11 Company Profiles
11.1 Eli Lilly & Company
11.1.1 Eli Lilly & Company Corporation Information
11.1.2 Eli Lilly & Company Description and Business Overview
11.1.3 Eli Lilly & Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly & Company Biologics Products Offered
11.1.5 Eli Lilly & Company Related Developments
11.2 Samsung Biologics
11.2.1 Samsung Biologics Corporation Information
11.2.2 Samsung Biologics Description and Business Overview
11.2.3 Samsung Biologics Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Samsung Biologics Biologics Products Offered
11.2.5 Samsung Biologics Related Developments
11.3 F Hoffman La Roche
11.3.1 F Hoffman La Roche Corporation Information
11.3.2 F Hoffman La Roche Description and Business Overview
11.3.3 F Hoffman La Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 F Hoffman La Roche Biologics Products Offered
11.3.5 F Hoffman La Roche Related Developments
11.4 Celltrion
11.4.1 Celltrion Corporation Information
11.4.2 Celltrion Description and Business Overview
11.4.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Celltrion Biologics Products Offered
11.4.5 Celltrion Related Developments
11.5 Addgene
11.5.1 Addgene Corporation Information
11.5.2 Addgene Description and Business Overview
11.5.3 Addgene Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Addgene Biologics Products Offered
11.5.5 Addgene Related Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Description and Business Overview
11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amgen Biologics Products Offered
11.6.5 Amgen Related Developments
11.7 Abbvie Inc.
11.7.1 Abbvie Inc. Corporation Information
11.7.2 Abbvie Inc. Description and Business Overview
11.7.3 Abbvie Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbvie Inc. Biologics Products Offered
11.7.5 Abbvie Inc. Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Biologics Products Offered
11.8.5 Sanofi Related Developments
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Corporation Information
11.9.2 Pfizer Inc. Description and Business Overview
11.9.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Pfizer Inc. Biologics Products Offered
11.9.5 Pfizer Inc. Related Developments
11.10 Merck & Co. Inc.
11.10.1 Merck & Co. Inc. Corporation Information
11.10.2 Merck & Co. Inc. Description and Business Overview
11.10.3 Merck & Co. Inc. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Merck & Co. Inc. Biologics Products Offered
11.10.5 Merck & Co. Inc. Related Developments
11.1 Eli Lilly & Company
11.1.1 Eli Lilly & Company Corporation Information
11.1.2 Eli Lilly & Company Description and Business Overview
11.1.3 Eli Lilly & Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eli Lilly & Company Biologics Products Offered
11.1.5 Eli Lilly & Company Related Developments
11.12 Johnson & Johnson Services Inc.
11.12.1 Johnson & Johnson Services Inc. Corporation Information
11.12.2 Johnson & Johnson Services Inc. Description and Business Overview
11.12.3 Johnson & Johnson Services Inc. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Johnson & Johnson Services Inc. Products Offered
11.12.5 Johnson & Johnson Services Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biologics Market Estimates and Projections by Region
12.1.1 Global Biologics Sales Forecast by Regions 2021-2026
12.1.2 Global Biologics Revenue Forecast by Regions 2021-2026
12.2 North America Biologics Market Size Forecast (2021-2026)
12.2.1 North America: Biologics Sales Forecast (2021-2026)
12.2.2 North America: Biologics Revenue Forecast (2021-2026)
12.2.3 North America: Biologics Market Size Forecast by Country (2021-2026)
12.3 Europe Biologics Market Size Forecast (2021-2026)
12.3.1 Europe: Biologics Sales Forecast (2021-2026)
12.3.2 Europe: Biologics Revenue Forecast (2021-2026)
12.3.3 Europe: Biologics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biologics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biologics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biologics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biologics Market Size Forecast by Region (2021-2026)
12.5 Latin America Biologics Market Size Forecast (2021-2026)
12.5.1 Latin America: Biologics Sales Forecast (2021-2026)
12.5.2 Latin America: Biologics Revenue Forecast (2021-2026)
12.5.3 Latin America: Biologics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biologics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biologics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biologics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biologics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biologics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biologics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Biologics Market Segments
Table 2. Ranking of Global Top Biologics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biologics Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Monoclonal Antibodies
Table 5. Major Manufacturers of Vaccines
Table 6. Major Manufacturers of Recombinant Proteins
Table 7. Major Manufacturers of Antisense
Table 8. Major Manufacturers of RNAi
Table 9. Global Biologics Market Size Growth Rate by Application 2020-2026 (MT)
Table 10. Global Biologics Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 11. Global Biologics Sales by Regions 2015-2020 (MT)
Table 12. Global Biologics Sales Market Share by Regions (2015-2020)
Table 13. Global Biologics Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Biologics Sales by Manufacturers (2015-2020) (MT)
Table 15. Global Biologics Sales Share by Manufacturers (2015-2020)
Table 16. Global Biologics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics as of 2019)
Table 18. Biologics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Biologics Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Biologics Price (2015-2020) (USD/MT)
Table 21. Biologics Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Biologics Product Type
Table 23. Date of International Manufacturers Enter into Biologics Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Biologics Sales by Type (2015-2020) (MT)
Table 26. Global Biologics Sales Share by Type (2015-2020)
Table 27. Global Biologics Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Biologics Revenue Share by Type (2015-2020)
Table 29. Biologics Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Biologics Sales by Application (2015-2020) (MT)
Table 31. Global Biologics Sales Share by Application (2015-2020)
Table 32. North America Biologics Sales by Country (2015-2020) (MT)
Table 33. North America Biologics Sales Market Share by Country (2015-2020)
Table 34. North America Biologics Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Biologics Revenue Market Share by Country (2015-2020)
Table 36. North America Biologics Sales by Type (2015-2020) (MT)
Table 37. North America Biologics Sales Market Share by Type (2015-2020)
Table 38. North America Biologics Sales by Application (2015-2020) (MT)
Table 39. North America Biologics Sales Market Share by Application (2015-2020)
Table 40. Europe Biologics Sales by Country (2015-2020) (MT)
Table 41. Europe Biologics Sales Market Share by Country (2015-2020)
Table 42. Europe Biologics Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Biologics Revenue Market Share by Country (2015-2020)
Table 44. Europe Biologics Sales by Type (2015-2020) (MT)
Table 45. Europe Biologics Sales Market Share by Type (2015-2020)
Table 46. Europe Biologics Sales by Application (2015-2020) (MT)
Table 47. Europe Biologics Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Biologics Sales by Region (2015-2020) (MT)
Table 49. Asia Pacific Biologics Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Biologics Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Biologics Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Biologics Sales by Type (2015-2020) (MT)
Table 53. Asia Pacific Biologics Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Biologics Sales by Application (2015-2020) (MT)
Table 55. Asia Pacific Biologics Sales Market Share by Application (2015-2020)
Table 56. Latin America Biologics Sales by Country (2015-2020) (MT)
Table 57. Latin America Biologics Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Biologics Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Biologics Revenue Market Share by Country (2015-2020)
Table 60. Latin America Biologics Sales by Type (2015-2020) (MT)
Table 61. Latin America Biologics Sales Market Share by Type (2015-2020)
Table 62. Latin America Biologics Sales by Application (2015-2020) (MT)
Table 63. Latin America Biologics Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Biologics Sales by Country (2015-2020) (MT)
Table 65. Middle East and Africa Biologics Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Biologics Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Biologics Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Biologics Sales by Type (2015-2020) (MT)
Table 69. Middle East and Africa Biologics Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Biologics Sales by Application (2015-2020) (MT)
Table 71. Middle East and Africa Biologics Sales Market Share by Application (2015-2020)
Table 72. Eli Lilly & Company Corporation Information
Table 73. Eli Lilly & Company Description and Major Businesses
Table 74. Eli Lilly & Company Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Eli Lilly & Company Product
Table 76. Eli Lilly & Company Recent Development
Table 77. Samsung Biologics Corporation Information
Table 78. Samsung Biologics Description and Major Businesses
Table 79. Samsung Biologics Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Samsung Biologics Product
Table 81. Samsung Biologics Recent Development
Table 82. F Hoffman La Roche Corporation Information
Table 83. F Hoffman La Roche Description and Major Businesses
Table 84. F Hoffman La Roche Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. F Hoffman La Roche Product
Table 86. F Hoffman La Roche Recent Development
Table 87. Celltrion Corporation Information
Table 88. Celltrion Description and Major Businesses
Table 89. Celltrion Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Celltrion Product
Table 91. Celltrion Recent Development
Table 92. Addgene Corporation Information
Table 93. Addgene Description and Major Businesses
Table 94. Addgene Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Addgene Product
Table 96. Addgene Recent Development
Table 97. Amgen Corporation Information
Table 98. Amgen Description and Major Businesses
Table 99. Amgen Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Amgen Product
Table 101. Amgen Recent Development
Table 102. Abbvie Inc. Corporation Information
Table 103. Abbvie Inc. Description and Major Businesses
Table 104. Abbvie Inc. Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Abbvie Inc. Product
Table 106. Abbvie Inc. Recent Development
Table 107. Sanofi Corporation Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Sanofi Product
Table 111. Sanofi Recent Development
Table 112. Pfizer Inc. Corporation Information
Table 113. Pfizer Inc. Description and Major Businesses
Table 114. Pfizer Inc. Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Pfizer Inc. Product
Table 116. Pfizer Inc. Recent Development
Table 117. Merck & Co. Inc. Corporation Information
Table 118. Merck & Co. Inc. Description and Major Businesses
Table 119. Merck & Co. Inc. Biologics Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Merck & Co. Inc. Product
Table 121. Merck & Co. Inc. Recent Development
Table 122. Novo Nordisk A/S Corporation Information
Table 123. Novo Nordisk A/S Description and Major Businesses
Table 124. Novo Nordisk A/S Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Novo Nordisk A/S Product
Table 126. Novo Nordisk A/S Recent Development
Table 127. Johnson & Johnson Services Inc. Corporation Information
Table 128. Johnson & Johnson Services Inc. Description and Major Businesses
Table 129. Johnson & Johnson Services Inc. Biologics Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Johnson & Johnson Services Inc. Product
Table 131. Johnson & Johnson Services Inc. Recent Development
Table 132. Global Biologics Sales Forecast by Regions (2021-2026) (MT)
Table 133. Global Biologics Sales Market Share Forecast by Regions (2021-2026)
Table 134. Global Biologics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 135. Global Biologics Revenue Market Share Forecast by Regions (2021-2026)
Table 136. North America: Biologics Sales Forecast by Country (2021-2026) (MT)
Table 137. North America: Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Europe: Biologics Sales Forecast by Country (2021-2026) (MT)
Table 139. Europe: Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Asia Pacific: Biologics Sales Forecast by Region (2021-2026) (MT)
Table 141. Asia Pacific: Biologics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 142. Latin America: Biologics Sales Forecast by Country (2021-2026) (MT)
Table 143. Latin America: Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Middle East and Africa: Biologics Sales Forecast by Country (2021-2026) (MT)
Table 145. Middle East and Africa: Biologics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Biologics Players
Table 150. Biologics Customers List
Table 151. Biologics Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologics Product Picture
Figure 2. Global Biologics Sales Market Share by Type in 2020 & 2026
Figure 3. Monoclonal Antibodies Product Picture
Figure 4. Vaccines Product Picture
Figure 5. Recombinant Proteins Product Picture
Figure 6. Antisense Product Picture
Figure 7. RNAi Product Picture
Figure 8. Global Biologics Sales Market Share by Application in 2020 & 2026
Figure 9. Infectious Diseases
Figure 10. Oncology
Figure 11. Immunology
Figure 12. Autoimmune Diseases
Figure 13. Biologics Report Years Considered
Figure 14. Global Biologics Market Size 2015-2026 (US$ Million)
Figure 15. Global Biologics Sales 2015-2026 (MT)
Figure 16. Global Biologics Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Biologics Sales Market Share by Region (2015-2020)
Figure 18. Global Biologics Sales Market Share by Region in 2019
Figure 19. Global Biologics Revenue Market Share by Region (2015-2020)
Figure 20. Global Biologics Revenue Market Share by Region in 2019
Figure 21. Global Biologics Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Biologics Revenue in 2019
Figure 23. Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Biologics Sales Market Share by Type (2015-2020)
Figure 25. Global Biologics Sales Market Share by Type in 2019
Figure 26. Global Biologics Revenue Market Share by Type (2015-2020)
Figure 27. Global Biologics Revenue Market Share by Type in 2019
Figure 28. Global Biologics Market Share by Price Range (2015-2020)
Figure 29. Global Biologics Sales Market Share by Application (2015-2020)
Figure 30. Global Biologics Sales Market Share by Application in 2019
Figure 31. Global Biologics Revenue Market Share by Application (2015-2020)
Figure 32. Global Biologics Revenue Market Share by Application in 2019
Figure 33. North America Biologics Sales Growth Rate 2015-2020 (MT)
Figure 34. North America Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Biologics Sales Market Share by Country in 2019
Figure 36. North America Biologics Revenue Market Share by Country in 2019
Figure 37. U.S. Biologics Sales Growth Rate (2015-2020) (MT)
Figure 38. U.S. Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Biologics Sales Growth Rate (2015-2020) (MT)
Figure 40. Canada Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Biologics Market Share by Type in 2019
Figure 42. North America Biologics Market Share by Application in 2019
Figure 43. Europe Biologics Sales Growth Rate 2015-2020 (MT)
Figure 44. Europe Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Biologics Sales Market Share by Country in 2019
Figure 46. Europe Biologics Revenue Market Share by Country in 2019
Figure 47. Germany Biologics Sales Growth Rate (2015-2020) (MT)
Figure 48. Germany Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Biologics Sales Growth Rate (2015-2020) (MT)
Figure 50. France Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Biologics Sales Growth Rate (2015-2020) (MT)
Figure 52. U.K. Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Biologics Sales Growth Rate (2015-2020) (MT)
Figure 54. Italy Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Biologics Sales Growth Rate (2015-2020) (MT)
Figure 56. Russia Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Biologics Market Share by Type in 2019
Figure 58. Europe Biologics Market Share by Application in 2019
Figure 59. Asia Pacific Biologics Sales Growth Rate 2015-2020 (MT)
Figure 60. Asia Pacific Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Biologics Sales Market Share by Region in 2019
Figure 62. Asia Pacific Biologics Revenue Market Share by Region in 2019
Figure 63. China Biologics Sales Growth Rate (2015-2020) (MT)
Figure 64. China Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Biologics Sales Growth Rate (2015-2020) (MT)
Figure 66. Japan Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Biologics Sales Growth Rate (2015-2020) (MT)
Figure 68. South Korea Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Biologics Sales Growth Rate (2015-2020) (MT)
Figure 70. India Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Biologics Sales Growth Rate (2015-2020) (MT)
Figure 72. Australia Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Biologics Sales Growth Rate (2015-2020) (MT)
Figure 74. Taiwan Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Biologics Sales Growth Rate (2015-2020) (MT)
Figure 76. Indonesia Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Biologics Sales Growth Rate (2015-2020) (MT)
Figure 78. Thailand Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Biologics Sales Growth Rate (2015-2020) (MT)
Figure 80. Malaysia Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Biologics Sales Growth Rate (2015-2020) (MT)
Figure 82. Philippines Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Biologics Sales Growth Rate (2015-2020) (MT)
Figure 84. Vietnam Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Biologics Market Share by Type in 2019
Figure 86. Asia Pacific Biologics Market Share by Application in 2019
Figure 87. Latin America Biologics Sales Growth Rate 2015-2020 (MT)
Figure 88. Latin America Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Biologics Sales Market Share by Country in 2019
Figure 90. Latin America Biologics Revenue Market Share by Country in 2019
Figure 91. Mexico Biologics Sales Growth Rate (2015-2020) (MT)
Figure 92. Mexico Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Biologics Sales Growth Rate (2015-2020) (MT)
Figure 94. Brazil Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Biologics Sales Growth Rate (2015-2020) (MT)
Figure 96. Argentina Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Biologics Market Share by Type in 2019
Figure 98. Latin America Biologics Market Share by Application in 2019
Figure 99. Middle East and Africa Biologics Sales Growth Rate 2015-2020 (MT)
Figure 100. Middle East and Africa Biologics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Biologics Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Biologics Revenue Market Share by Country in 2019
Figure 103. Turkey Biologics Sales Growth Rate (2015-2020) (MT)
Figure 104. Turkey Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Biologics Sales Growth Rate (2015-2020) (MT)
Figure 106. Saudi Arabia Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Biologics Sales Growth Rate (2015-2020) (MT)
Figure 108. U.A.E Biologics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Biologics Market Share by Type in 2019
Figure 110. Middle East and Africa Biologics Market Share by Application in 2019
Figure 111. North America Biologics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 112. North America Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Biologics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. Europe Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Biologics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Asia Pacific Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Biologics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Latin America Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Biologics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. Middle East and Africa Biologics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nucleotide Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 132

Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......

Global Nucleotide Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 165

Nucleotides are organic molecules consisting of a nucleoside and a phosphate. They serve as monomeric units of the nucleic acid polymers deoxyribonucleic acid and ribonucleic acid, both of which are essential biomolecules within all life-forms on Earth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This wa......

Global Bioburden Testing Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120

Report Overview: The Global Bioburden Testing Market Size was estimated at USD 898.90 million in 2022 and is projected to reach USD 1443.44 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Bioburden Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market dri......

Global qPCR Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Nov-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global qPCR market: According to our latest research, the global qPCR market looks promising in the next 5 years. As of 2022, the global qPCR market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global qPCR market, with a systematical description of the status ......

Global Interferon Market Research Report 2023, Forecast to 2028

Published: 01-Nov-2023        Price: US 2680 Onwards        Pages: 131

Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......

Global Interferon Professional Survey Report 2023, Forecast to 2028

Published: 01-Nov-2023        Price: US 3280 Onwards        Pages: 107

Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. And they trigger killer immune cells to fight those invaders. Interferons got their name because they "interfere" with viruses and keep them from multiplying. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......

Global Biologics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Oct-2023        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Biologics market: According to our latest research, the global Biologics market looks promising in the next 5 years. As of 2022, the global Biologics market was estimated at USD 251622.83 million, and it's anticipated to reach USD 363588.32 million in 2028, with a CAGR of 6.33% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Biologics market, with a sys......

Global Nucleotide Market Insights, Forecast to 2029

Published: 25-Sep-2023        Price: US 4900 Onwards        Pages: 89

Nucleotides are small organic molecules composed of purine bases or pyrimidine bases, pentoses and phosphoric acid. They are the structural units of nucleic acids, and their derivatives have a variety of biological functions. It can be used in the fields of food, pharmaceuticals and feed additive. The global Nucleotide market is projected to grow from US$ 511.1 million in 2023 to US$ 492.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.6% during the forecast period. ......

2023-2031 Report on Global Nucleotide Market by Player, Region, Type, Application and Sales Channel

Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 89

This report studies the Nucleotide market, covering market size for segment by type (Food Grade Nucleotide, Lab Grade Nucleotide, etc.), by application (Pharmaceuticals, Food & Beverage Additives, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AJINOMOTO, CJ, DAESANG, Meihua Group, Star Lake Bioscience, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of g......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs